Peter Thompson, M.D., is co-founder, president, and CEO of Silverback Therapeutics. He also serves as chairman of the board of directors. Dr. Thompson is a private equity partner at OrbiMed, a leading global healthcare-dedicated investment firm. He has more than 25 years of biotechnology industry experience, including co-founding Corvus Pharmaceuticals, Cleave Biosciences, and Edgewise Therapeutics. He also co-founded and served as CEO of Trubion Pharmaceuticals and held executive roles at Becton-Dickinson and Chiron. Dr. Thompson is an inventor on numerous patents and is a board-certified internist and oncologist, having trained at the National Cancer Institute and Yale University after receiving his M.D. from Brown Medical School.